Some opportunistic parasitic infections in AIDS: Candidiasis, Pneumocystosis, Cryptosporidiosis, Toxoplasmosis

Parasitology Today

Volumn 14, Issue 4, 1998, Pages 150-156

  Kasper, L H ^a   Buzoni Gatel, D ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANDIDA ALBICANS; CANDIDIASIS; CELLULAR IMMUNITY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; CYTOKINE RELEASE; DISEASE COURSE; GENETIC PREDISPOSITION; HOST PARASITE INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOCYTE COUNT; OPPORTUNISTIC INFECTION; PARASITE VIRULENCE; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; REVIEW; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0032053835     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(97)01212-X     Document Type: Review

References (86)

1. Lucht E., Nord C.E. Opportunistic oral infections in patients infected with HIV-1. Rev. Med. Microbiol. 7:1996;151-163.
2. Odds, F.C. (1988) Candida and Candidiasis, 2nd edn, Baillière Tindall.
3. Hostetter M.K. An integrin-like protein in Candida albicans: implications for pathogenesis. Trends Microbiol. 4:1996;242-246.
4. Glee P.M., Sundstrom P., Hazen K.C. Expression of surface hydrophobic proteins by Candida albicans in vivo. Infect. Immun. 63:1995;1373-1379.
5. Klotz S.A., Smith R.L. A fibronectin receptor on Candida albicans mediates adherence of the fungus to extracellular matrix. J. Infect. Dis. 163:1991;604-610.
6. Ollert M.W.et al. Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect. Immun. 61:1993;4560-4568.
7. Segal E., Lehrer N., Ofck I. Adherence of Candida albicans to human vaginal epithelial cells: inhibition by amino sugar. Exp. Cell. Biol. 50:1982;13-17.
8. Sobel J.D.et al. Adherence of Candida albicans to human vaginal and buccal epithelial cells. J. Infect. Dis. 143:1981;76-82.
9. De Bernardis F.et al. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect. Immun. 64:1996;466-471.
10. Ibrahim A.et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect. Immun. 63:1995;1993-1998.
11. Manns J.M., Mosser D.M., Buckley H.R. Production of a hemolytic factor by Candida albicans. Infect. Immun. 62:1994;5154-5156.
12. Diez-Orejas R.et al. Reduced virulence of Candida albicans MKC1 mutants: a role for mitogen-activated protein kinase in pathogenesis. Infect. Immun. 65:1997;833-837.
13. Blasi E.et al. Tumor necrosis factor as an autocrine and paracrine signal controlling the macrophage secretory response to Candida albicans. Infect. Immun. 62:1994;1199-1206.
14. Blasi E.et al. Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin 1. Infect. Immun. 58:1990;1073-1077.
15. Blasi E.et al. Differential susceptibility of yeast and hyphal forms of Candida albicans to proteolytic activity of macrophages. Infect. Immun. 63:1995;1253-1257.
16. Filler S.G.et al. Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect. Immun. 64:1996;2609-2617.
17. Ashman R.B., Papadimitrious J.M. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol. Rev. 59:1995;646-672.
18. + T-helper-cell response in mice with low-level Candida albicans infection. Infect. Immun. 64:1996;4907-4914.
19. Witkin S.S. Inhibition of Candida-induced lymphocyte proliferation by antibody to Candida albicans. Obstet. Gynecol. 68:1986;696-699.
20. Cailliez J.C.et al. Pneumocystis carinii: an atypical fungal micro-organism. J. Med. Vet. Mycol. 34:1996;227-239.
21. Pottratz S.T.et al. Evidence for Pneumocystis carinii binding to a cell-free substrate: role of the adhesive protein fibronectin. J. Lab. Clin. Med. 123:1994;273-281.
22. Limper A.H.et al. Vibronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect. Immun. 61:1993;4302-4309.
23. Furlong S.T.et al. Lipid transfer from human epithelial cells to Pneumocystis carinii in vitro. J. Infect. Dis. 175:1997;661-668.
24. Limper A.H., Hoyte J.S., Standing J.E. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J. Clin. Invest. 99:1997;2110-2117.
25. Williams M.D.et al. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages. Am. J. Resp. Cell. Mol. Biol. 14:1996;232-238.
26. Hidalgo H.A.et al. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect. Immun. 60:1992;1-7.
27. Hoffman O.A., Standing J.E., Limper A.H. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J. Immunol. 150:1993;3932-3940.
28. Neese L.W.et al. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-α in response to Pneumocystis carinii. J. Immunol. 152:1994;4549-4556.
29. Chen W.et al. Interleukin 1: an important mediator of host resistance against Pneumocystis carinii. J. Exp. Med. 176:1992;713-718.
30. Pottratz S.T., Weir A.L. Gamma interferon inhibits Pneumocystis carinii attachment to lung cells by decreasing expression of lung cell-surface integrins. Eur. J. Clin. Invest. 27:1997;17-22.
31. Garvy B.A., Ezekowitz R.A., Harmsen A.G. Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection. Infect. Immun. 65:1997;373-379.
32. + lymphocytes in host defense against Pneumocystis carinii in mice. J. Lab. Clin. Med. 128:1996;477-487.
33. O'Donoghue P. Cryptosporidium and cryptosporidiosis in man and animals. Int. J. Parasitol. 25:1995;139-195.
34. Hamer D.H.et al. Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro. Infect. Immun. 62:1994;2208-2213.
35. Tilley M.et al. Identification of a 15-Kilodalton surface glycoprotein on sporozoites of Cryptosporidium parvum. Infect. Immun. 59:1991;1002-1007.
36. Clark D.P., Sears C.L. The pathogenesis of cryptosporidiosis. Parasitol. Today. 12:1996;221-225.
37. Peeters J.E.et al. Cryptosporidium parvum in calves: kinetics and immunoblot analysis of specific serum and local antibody responses [Immunoglobulin A (IgA), IgG and IgM] after natural and experimental infections. Infect. Immun. 60:1992;2309-2316.
38. Taghi-Kilani R., Sekla L., Hayglass K.T. The role of humoral immunity in Cryptosporidium spp. infections, studies with B-cell depleted mice. J. Immunol. 145:1990;1571-1576.
39. Gomez Morales M.A., Pozio E., Croppo G.P. Detection of Cryptosporidium circulating antigens in human and calf sera. J. Protozool. 38(Suppl.):1991;182S-183S.
40. Riggs M.W.et al. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice. Infect. Immun. 62:1994;1927-1939.
41. Greenberg P.D., Cello J.P. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J. AIDS Hum. Retrovirol. 13:1996;348-354.
42. Doyle P.S., Crabb J., Petersen C. Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo. Infect. Immun. 61:1993;4079-4084.
43. Perryman L.E., Mason P.H., Chrisp C.E. Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice. Infect. Immun. 62:1994;1474-1477.
44. McDonald V.et al. Cryptosporidium muris in adult mice: adoptive transfer of immunity and protective roles of CD4 versus CD8 cells. Infect. Immun. 62:1994;2289-2294.
45. + T lymphocytes in protective immunity. J. Immunol. 147:1991;1014-1022.
46. Wyatt C.R.et al. Activation of intestinal intraepithelial T lymphocytes in calves infected with Cryptosporidium parvum. Infect. Immun. 65:1997;185-190.
47. + intraepithelial lymphocytes. Infect. Immun. 64:1996;2556-2562.
48. Mineo J.R., Kasper L.H. Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG-1 (p30). Exp. Parasitol. 79:1994;11-20.
49. Furtado G.C.et al. Laminin enhances binding of Toxoplasma gondii tachyzoites to J774 murine macrophage cells. Infect. Immun. 60:1992;2337-2342.
50. Grimwood J., Mineo J.R., Kasper L.H. Attachment of Toxoplasma gondii to host cells is host cell cycle dependent. Infect. Immun. 64:1996;4099-4104.
51. Furtado G.C., Cao Y., Joiner K.A. Laminin on Toxoplasma gondii mediates parasite binding to the beta 1 integrin receptor alpha 6 beta 1 on human foreskin fibroblasts and Chinese hamster ovary cells. Infect. Immun. 60:1992;4925-4931.
52. Mineo J.R.et al. Antibodies to Toxoplasma gondii major surface protein (SAG-1, p30) inhibit infection of host cells and are produced in murine intestine after peroral infection. J. Immunol. 150:1993;3951-3964.
53. Fourmaux M.N.et al. The MIC1 microneme protein of Toxoplasma gondii contains a duplicated receptor-like domain and binds to host cell surface. Mol. Biochem. Parasitol. 83:1996;201-210.
54. Fourmaux M.N.et al. Toxoplasma gondii microneme proteins: gene cloning and possible function. Curr. Top. Microbiol. Immunol. 219:1996;55-58.
55. Tomavo S. The major surface proteins of Toxoplasma gondii: structures and functions. Curr. Top. Microbiol. Immunol. 219:1996;45-54.
56. Cesbron-Delauw M.F.et al. Similarities between the primary structures of two distinct major surface proteins of Toxoplasma gondii. J. Biol. Chem. 269:1994;16217-16222.
57. Hunter C.A.et al. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect. Immun. 62:1994;2818-2824.
58. Khan I.A.et al. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice. J. Immunol. 156:1996;636-643.
59. Scharton-Kersten T.et al. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1997;1261-1273.
60. Khan I.A.et al. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc. Natl. Acad. Sci. U. S. A. 94:1997;13955-13960.
61. + T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:1991;286-292.
62. + T cell clone protects against acute Toxoplasma gondii infection in mice. J. Immunol. 152:1994;1856-1860.
63. + T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J. Immunol. 147:1991;2310-2316.
64. Suzuki Y., Remington J.S. The effect of anti IFN-γ antibody on the protective effect of Lyt-2 immune T cells against toxoplasma in mice. J. Immunol. 144:1990;1954-1956.
65. Buzoni-Gatel D.et al. Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii. J. Immunol. 158:1997;5883-5889.
66. Chardes T.et al. Toxoplasma gondii oral infection induces specific cytotoxic CD8 α/β+, Thy-1+ gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. J. Immunol. 153:1994;4596-4603.
67. Gazzinelli R.T.et al. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:1994;2533-2543.
68. Khan I.A., Matsuura T., Kasper L.H. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 62:1994;1639-1642.
69. Suzuki Y.et al. IL-4 is protective against development of toxoplasmic encephalitis. J. Immunol. 157:1996;2564-2569.
70. Beaman M.H., Hunter C.A., Remington J.S. Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-gamma and TNF-alpha. J. Immunol. 153:1994;4583-4587.
71. Kasper L.H., Matsuura T., Khan I.A. IL-7 stimulates protective immunity in mice against the intracellular pathogen, Toxoplasma gondii. J. Immunol. 155:1995;4798-4804.
72. + cell mediated immunity against Toxoplasma gondii infection in mice. J. Immunol. 157:1996;2103-2108.
73. Sousa C.R.et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186:1997;1819-1829.
74. Guo Z.G., Gross U., Johnson A.M. Toxoplasma gondii virulence markers identified by random amplified polymeric DNA polymerase chain reaction. Parasitol. Res. 83:1977;458-463.
75. Howe D.K., Summers B.C., Sibley L.D. Acute virulence in mice is associated with markers on chromosome VIII in Toxoplasma gondii. Infect. Immun. 64:1996;5193-5198.
76. Dardé M.L. Biodiversity in Toxoplasma gondii. Curr. Top. Microbiol. Immunol. 219:1996;27-41.
77. Clark D.P., Sears C.L. The pathogenesis of cryptosporidiosis. Parasitol. Today. 12:1996;221-225.
78. Beck J.M., Newbury R.L., Palmer B.E. Pneumocystis carinii pneumonia in scid mice induced by viable organisms propagated in vitro. Infect. Immun. 64:1996;4643-4647.
79. Stringer J.R. Pneumocystis carinii: what is it exactly? Clin. Microbiol. Rev. 9:1996;489-498.
80. Kirsh D.R., Whitney R.R. Pathogenicity of Candida albicans auxotrophic mutants in experimental infections. Infect. Immun. 59:1991;3297-3300.
81. Baskin G.B.et al. Correlation of major histocompatibility complex with opportunistic infections in simian immunodeficiency virus-infected rhesus monkeys. Lab. Invest. 77:1997;305-309.
82. Davami M.H., Bancroft G.J., McDonald V. Cryptosporidium infection in major histocompatibility complex congenic mice: variation in susceptibility and the role of T-cell cytokine responses. Parasitol. Res. 83:1977;257-263.
83. Blackwell J.M., Roberts C.W., Alexander J. Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice. Parasite Immunol. 15:1993;317-324.
84. Brown C.R.et al. Definitive identification of a gene that confers resistance against Toxoplasma cysts burden and encephalitis. Immunology. 85:1995;419-428.
85. Ashman R.B., Papadimitriou J.M. Murine candidiasis; Pathogenesis and host response in genetically distinct inbred mice. Immunol. Cell. Biol. 65:1987;163-171.
86. McLeod R.et al. Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of AxB/BxA recombinant inbred and B10 congenic mice. J. Immunol. 143:1989;3031-3034.